Published in the March 2009 Kansas State Board of Pharmacy Newsletter
The Board of Pharmacy added BZP to its Schedule I list. BZP is the common name for the synthetic drug Nbenzylpiperazine, a stimulant that is approximately 10 to 20 times more potent than amphetamine. It is promoted as an alternative to ecstasy. BZP primarily is abused by teenagers and young adults. The drug often is used at raves, nightclubs, private parties, and other venues where the use of club drugs, particularly ecstasy, is well established. The risks associated with BZP abuse are similar to those associated with amphetamine abuse. In March 2004 DEA designated BZP a Schedule I substance under the Controlled Substance Act. This drug is now showing up in Kansas and several county and district attorneys asked that this drug be placed on the state Schedule I list.